NEULACTIL

This brand name is authorized in Australia, Hong Kong SAR China, New Zealand.

Active ingredients

The drug NEULACTIL contains one active pharmaceutical ingredient (API):

1
UNII 3405M6FD73 - PERICIAZINE
 

Pericyazine is a neuroleptic with cardiovascular and antihistamine effects similar to those of chlorpromazine, but it has a stronger antiserotonin effect and a powerful central sedative effect.

 
Read more about Periciazine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N05AC01 Periciazine N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AC Phenothiazines with piperidine structure
Discover more medicines within N05AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 3052P, 3053Q
HK Department of Health Drug Office 31134, 31135
NZ Medicines and Medical Devices Safety Authority 476, 477

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.